| Year |
Citation |
Score |
| 2020 |
N Haines C, Klingensmith HD, Komara M, Burd CJ. GREB1 regulates PI3K/Akt signaling to control hormone-sensitive breast cancer proliferation. Carcinogenesis. PMID 32894276 DOI: 10.1093/carcin/bgaa096 |
0.341 |
|
| 2018 |
Haines CN, Braunreiter KM, Mo XM, Burd CJ. GREB1 isoforms regulate proliferation independent of ERα co-regulator activities in breast cancer. Endocrine-Related Cancer. PMID 29695586 DOI: 10.1530/ERC-17-0496 |
0.353 |
|
| 2013 |
Augello MA, Burd CJ, Birbe R, McNair C, Ertel A, Magee MS, Frigo DE, Wilder-Romans K, Shilkrut M, Han S, Jernigan DL, Dean JL, Fatatis A, McDonnell DP, Visakorpi T, et al. Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes. The Journal of Clinical Investigation. 123: 493-508. PMID 23257359 DOI: 10.1172/Jci64750 |
0.738 |
|
| 2012 |
Burd CJ, Ward JM, Crusselle-Davis VJ, Kissling GE, Phadke D, Shah RR, Archer TK. Analysis of chromatin dynamics during glucocorticoid receptor activation. Molecular and Cellular Biology. 32: 1805-17. PMID 22451486 DOI: 10.1128/Mcb.06206-11 |
0.353 |
|
| 2012 |
Augello MA, Burd C, Bribe R, Frigo D, Karch J, McDonnell D, Visakorpi T, Knudsen KE. Abstract A50: Cyclin D1 isoforms selectively manipulate AR signaling to promote metastatic phenotypes in early and castration-resistant prostate cancer. Cancer Research. 72: A50-A50. DOI: 10.1158/1538-7445.Prca2012-A50 |
0.802 |
|
| 2011 |
Comstock CE, Augello MA, Schiewer MJ, Karch J, Burd CJ, Ertel A, Knudsen ES, Jessen WJ, Aronow BJ, Knudsen KE. Cyclin D1 is a selective modifier of androgen-dependent signaling and androgen receptor function. The Journal of Biological Chemistry. 286: 8117-27. PMID 21212260 DOI: 10.1074/Jbc.M110.170720 |
0.793 |
|
| 2010 |
Augello M, Burd C, Karch J, Knudsen K. Abstract 3878: Perturbations in the AR-cyclin D1 axis controls lethal tumor phenotypes in prostate cancer Cancer Research. 70: 3878-3878. DOI: 10.1158/1538-7445.Am10-3878 |
0.806 |
|
| 2009 |
Comstock CE, Augello MA, Benito RP, Karch J, Tran TH, Utama FE, Tindall EA, Wang Y, Burd CJ, Groh EM, Hoang HN, Giles GG, Severi G, Hayes VM, Henderson BE, et al. Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 5338-49. PMID 19706803 DOI: 10.1158/1078-0432.Ccr-08-2865 |
0.779 |
|
| 2009 |
Schiewer MJ, Morey LM, Burd CJ, Liu Y, Merry DE, Ho SM, Knudsen KE. Cyclin D1 repressor domain mediates proliferation and survival in prostate cancer Oncogene. 28: 1016-1027. PMID 19079343 DOI: 10.1038/Onc.2008.446 |
0.781 |
|
| 2008 |
Wang Y, Dean JL, Millar EK, Tran TH, McNeil CM, Burd CJ, Henshall SM, Utama FE, Witkiewicz A, Rui H, Sutherland RL, Knudsen KE, Knudsen ES. Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists. Cancer Research. 68: 5628-38. PMID 18632615 DOI: 10.1158/0008-5472.Can-07-3170 |
0.667 |
|
| 2008 |
Olshavsky NA, Groh EM, Comstock CE, Morey LM, Wang Y, Revelo MP, Burd C, Meller J, Knudsen KE. Cyclin D3 action in androgen receptor regulation and prostate cancer. Oncogene. 27: 3111-21. PMID 18084330 DOI: 10.1038/Sj.Onc.1210981 |
0.805 |
|
| 2006 |
Burd CJ, Morey LM, Knudsen KE. Androgen receptor corepressors and prostate cancer. Endocrine-Related Cancer. 13: 979-94. PMID 17158750 DOI: 10.1677/Erc.1.01115 |
0.744 |
|
| 2006 |
Burd CJ, Petre CE, Morey LM, Wang Y, Revelo MP, Haiman CA, Lu S, Fenoglio-Preiser CM, Li J, Knudsen ES, Wong J, Knudsen KE. Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation Proceedings of the National Academy of Sciences of the United States of America. 103: 2190-2195. PMID 16461912 DOI: 10.1073/Pnas.0506281103 |
0.795 |
|
| 2005 |
Link KA, Burd CJ, Williams E, Marshall T, Rosson G, Henry E, Weissman B, Knudsen KE. BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF Molecular and Cellular Biology. 25: 2200-2215. PMID 15743818 DOI: 10.1128/Mcb.25.6.2200-2215.2005 |
0.733 |
|
| 2005 |
Petre-Draviam CE, Williams EB, Burd CJ, Gladden A, Moghadam H, Meller J, Diehl JA, Knudsen KE. A central domain of cyclin D1 mediates nuclear receptor corepressor activity. Oncogene. 24: 431-44. PMID 15558026 DOI: 10.1038/Sj.Onc.1208200 |
0.735 |
|
| 2005 |
Burd CJ, Petre CE, Moghadam H, Wilson EM, Knudsen KE. Cyclin D1 binding to the androgen receptor (AR) NH2-terminal domain inhibits activation function 2 association and reveals dual roles for AR corepression. Molecular Endocrinology (Baltimore, Md.). 19: 607-20. PMID 15539430 DOI: 10.1210/Me.2004-0266 |
0.738 |
|
| 2003 |
Petre-Draviam CE, Cook SL, Burd CJ, Marshall TW, Wetherill YB, Knudsen KE. Specificity of cyclin D1 for androgen receptor regulation. Cancer Research. 63: 4903-13. PMID 12941814 |
0.732 |
|
| 2003 |
Liby K, Neltner B, Mohamet L, Burd C, Ben-Jonathan N. Endostatin expression by MDA-MB-435 breast cancer cells effectively inhibits tumor growth. Cancer Biology & Therapy. 2: 48-52. PMID 12673115 DOI: 10.4161/Cbt.179 |
0.376 |
|
| 2003 |
Singleton DW, Feng Y, Burd CJ, Khan SA. Nongenomic activity and subsequent c-fos induction by estrogen receptor ligands are not sufficient to promote deoxyribonucleic acid synthesis in human endometrial adenocarcinoma cells. Endocrinology. 144: 121-8. PMID 12488337 DOI: 10.1210/En.2002-220625 |
0.404 |
|
| Show low-probability matches. |